Lupin has informed that it enclosed a Press release regarding receipt of US FDA approval for the Company’s Abbreviated New Drug Application for Ganirelix Acetate Injection, 250 mcg/0.5 mL Single-Dose Prefilled Syringe, to market a generic equivalent to the reference listed drug of Ganirelix Acetate Injection, 250 mcg/0.5 mL of Organon USA LLC.
The above information is a part of company’s filings submitted to BSE.